Administration of mTOR1 inhibitor (MLN0128) and genetic ablation of Raptor (the unique subunit of mTORC1) was shown to inhibit cell growth in hepatoblastoma cells and delay YAP/β-catenin-induced development of hepatoblastoma in mice, respectively. Here, YAP1 is linked to hepatoblastoma.